Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial plasma membrane phospholipids are a diverse group of amphipathic lipids that comprise the primary structural framework of bacterial plasma membranes[2][8]. Each molecule consists of a polar (hydrophilic) head group and nonpolar (hydrophobic) fatty acid tails, spontaneously forming a bilayer in aqueous environments[1][5][6]. In bacteria, these phospholipids vary in chain length, saturation, and composition, affecting membrane properties such as fluidity and charge[2][3][8]. The lipid bilayer acts as a selective barrier between cellular contents and the external environment, supporting membrane protein functions and cellular compartmentalization[1][3][7]. Unlike animal membranes, bacterial membranes usually lack cholesterol[6][8]. Some antimicrobial drugs target these lipids, disrupting barrier function and causing bacterial cell death, but such drugs (e.g., polymyxins) carry risks of toxicity and resistance[8].
Membrane disruption/destabilization (leading to cell lysis) Increased membrane permeability (causing leakage of cellular contents)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial plasma membrane phospholipids.